The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...
In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.
Alteplase improves stroke recovery by over 50% when given up to 24 hours after symptom onset, offering hope for patients with ...
Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to ...
Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...
This prospective case-control study included 85 patients with lung involvement related to the COVID-19 virus and a group of ...
University of Cincinnati experts will present research at the International Stroke Conference 2025 in Los Angeles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback